Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8479246 | Neurochemistry International | 2014 | 7 Pages |
Abstract
We conclude that VGLUT inhibitors can modulate glutamatergic synaptic transmission in the PFC and hippocampus. This could be important in the pathophysiology of nervous system disorders and might represent a target for developing novel pharmacological therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
S.A. Neale, C.S. Copeland, T.E. Salt,